We found that low expressed genes (except PTPRN2) were associated with worse DFS as indicated by the presence of biochemical recurrence (rising PSA levels following local therapy) or radiological tumor recurrence/metastasis56. This evidence concerns the gene PTPRN2 and neoplasm.